ERBITUX CETUXIMAB
Live / Registered — Registered and renewed (as of 19 Nov 2017)
What this means for you
Registered since 13 Nov 2007. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 13 Nov 2017).
Record
- Serial number
- 76670452
- Registration number
- 3333263
- Mark type
- Design + words
- Filed
- 18 Dec 2006
- Published for opposition
- 28 Aug 2007
- Registered
- 13 Nov 2007
- Next maintenance due
- 13 Nov 2017
- Attorney of record
- Bruce W. Longbottom
Goods and services
- Class 005 — Pharmaceuticals: PHARMACEUTICAL PREPARATION, NAMELY MONOCLONAL ANTIBODY FOR THE TREATMENT OF CANCER
Owner
- ImClone LLC, New York, NY, US
- ImClone Systems Incorporated, New York, NY, US
- ImClone Systems Incorporated, New York, NY, US
- ImClone Systems Incorporated, New York, NY, US
Prior registrations
Prosecution history
- 19 Nov 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 19 Nov 2017 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 19 Nov 2017 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 19 Nov 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Oct 2017 — TEAS SECTION 8 & 9 RECEIVED
- 13 Nov 2016 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 22 Nov 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 22 Nov 2013 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Nov 2013 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 21 Nov 2013 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 08 Nov 2013 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Nov 2013 — TEAS SECTION 8 & 15 RECEIVED
- 03 Jun 2009 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Jun 2009 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Feb 2009 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY